Table of Contents
CARMA: Campylobacter Risk Management and Assessment
Campylobacter jejuni
CARMA is a collaboration between ...
Goals of the CARMA project
Information to support decision making
Risk profile: major conclusions
Incidence of Campylobacter associated illness (per year, population 16 million)
Trend in laboratory reported cases of human campylobacteriosis
Age distribution
Seasonal variation
Sources of Campylobacter
Prevalence of Campylobacter in broilers
Prevalence of Campylobacter in poultry products (retail)
Risk modelling
MPRM kipfilet schema
General approach of CARMA (1)
General approach of CARMA (2)
Interventions to be evaluated
Cost-effectiveness analysis
Costs of campylobacteriosis in the Netherlands (global estimate, Bunte et al., 2001)
DALYs as unit measures for disease burden
Disease burden of infection with thermophilic Campylobacter spp. in the Netherlands
Possible outcomes
Cost - effectiveness of preventing gastro-enteritis: a hypothetical example
Conclusion
|